Cargando…
Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study
OBJECTIVES: This is the first clinical trial of this type in Japan, designed to analyze two important aspects of Alzheimer’s disease (AD) management using medium-chain triglycerides. Axona was administered for 3 months (40 g of powder containing 20 g of caprylic triglycerides). We used an indurating...
Autores principales: | Ohnuma, Tohru, Toda, Aiko, Kimoto, Ayako, Takebayashi, Yuto, Higashiyama, Ryoko, Tagata, Yuko, Ito, Masanobu, Ota, Tsuneyoshi, Shibata, Nobuto, Arai, Heii |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712972/ https://www.ncbi.nlm.nih.gov/pubmed/26811674 http://dx.doi.org/10.2147/CIA.S95362 |
Ejemplares similares
-
No Associations Found between PGBD1 and the Age of Onset in Japanese Patients Diagnosed with Sporadic Alzheimer's Disease
por: Ohnuma, Tohru, et al.
Publicado: (2012) -
Genetic Association between Akt1 Polymorphisms and Alzheimer's Disease in a Japanese Population
por: Shibata, Nobuto, et al.
Publicado: (2011) -
Age-Related Association between Apolipoprotein E ε4 and Cognitive Function in Japanese Patients with Alzheimer's Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2013) -
Genetic Association between Neurotrophin-3 Polymorphisms and Alzheimer's Disease in Japanese Patients
por: Nagata, Tomoyuki, et al.
Publicado: (2013) -
Genetic or Psychogenic? A Case Study of “Folie à Quatre” Including Twins
por: Ohnuma, Tohru, et al.
Publicado: (2015)